Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takanobu Yoshimoto

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 21, 2016
[Programs for Continuing Medical Education: A session; 3. Primary aldosteronism as a cause of secondary hypertension]Yoshihiro Ogawa, Takanobu Yoshimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2007
[Bosentan for treatment of heart failure]Takanobu Yoshimoto, Yukio Hirata
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2004
[Autocrine/paracrine role of urotensin II as a growth factor]Takanobu Yoshimoto, Yukio Hirata
Endocrine Journal|April 6, 2007
Aldosterone as a cardiovascular risk hormoneTakanobu Yoshimoto, Yukio Hirata
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 12, 2011
[Pharmacological therapy for primary aldosteronism]Takanobu Yoshimoto, Yukio Hirata
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 24, 2004
[Anti-hypertensive drugs associated with the improvement of endothelial function]Takanobu Yoshimoto, Yukio Hirata
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 19, 2007
[Endothelin]Takanobu Yoshimoto, Yukio Hirata
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 12, 2011
[Clinical concept of ectopic hormone producing tumor]Takanobu Yoshimoto, Yukio Hirata
Peptides|October 13, 2004
Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factorTakanobu Yoshimoto, Mika Matsushita, Yukio Hirata
Endocrine Journal|April 9, 2009
Endothelial dysfunction is related to aldosterone excess and raised blood pressureKyoichiro Tsuchiya, Takanobu Yoshimoto, Yukio Hirata
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 21, 2016
[Programs for Continuing Medical Education: A session; 3. Primary aldosteronism as a cause of secondary hypertension]Yoshihiro Ogawa, Takanobu Yoshimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2007
[Bosentan for treatment of heart failure]Takanobu Yoshimoto, Yukio Hirata
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2004
[Autocrine/paracrine role of urotensin II as a growth factor]Takanobu Yoshimoto, Yukio Hirata
Endocrine Journal|April 6, 2007
Aldosterone as a cardiovascular risk hormoneTakanobu Yoshimoto, Yukio Hirata
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 12, 2011
[Pharmacological therapy for primary aldosteronism]Takanobu Yoshimoto, Yukio Hirata
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 24, 2004
[Anti-hypertensive drugs associated with the improvement of endothelial function]Takanobu Yoshimoto, Yukio Hirata
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 19, 2007
[Endothelin]Takanobu Yoshimoto, Yukio Hirata
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 12, 2011
[Clinical concept of ectopic hormone producing tumor]Takanobu Yoshimoto, Yukio Hirata
Peptides|October 13, 2004
Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factorTakanobu Yoshimoto, Mika Matsushita, Yukio Hirata
Endocrine Journal|April 9, 2009
Endothelial dysfunction is related to aldosterone excess and raised blood pressureKyoichiro Tsuchiya, Takanobu Yoshimoto, Yukio Hirata
Pageof 15